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Rutin is a unique antioxidant flavonoid that is mainly found in fruit, vegetables, cereals, and many other plant-based human diets.
(is review aims to highlight the in vitro anticancer properties of rutin including combination therapeutic strategies. Literature
resources were gathered through PubMed, Scopus,Web of Science, andGoogle Scholar databases that cover the period of 1995–2021.
Rutin is demonstrated to inhibit the proliferation of breast, colon, lung, and prostate cancers and other tumors. Furthermore, rutin
alone or in combination with other therapeutic agents has been shown to regulate several signalling pathways involving the Ras/Raf
and PI3K/Akt, MAPK, and TGF-β2/Smad2/3Akt/PTEN, etc., which are related to the processes of carcinogenesis and induction of
apoptosis. (e combination of rutin with other chemotherapy drugs may benefit on prevention of tumor cells by decreasing drug
resistance and chemotherapy side effects. Moreover, rutin induces apoptosis synergistically with the therapeutic agent. More in vivo
and clinical data are however needed to evaluate the true potential of rutin as an anticancer agent as an adjuvant. (e present review
highlights the effects of rutin which can be a promising candidate in combination with other antitumor drugs or alone for cancer
treatment in vitro. Also, rutin can lead to decrease in drug resistance and chemotherapeutic side effects.
1. Introduction
1.1. Chemical Structure of Rutin as a Flavonoid. (e 15-
carbon basic structure of flavonoids consists of a three-ring
system arranged as C6-C3-C6. (is normally includes two
aromatic rings (rings A and B) often in polyphenolic forms
joined together with a three-carbon chain to form the third
ring (ring C) in many flavonoids. Depending on the oxi-
dation state, presence or absence of double bond, and the
way ring C is connected with ring B, flavonoids are classified
into different families such as flavonols, flavones, and fla-
vanones [1]. Biosynthetically, the first group of flavonoids
that are considered precursors are the chalcones. Naringenin
chalcone is one of the first chalcone derivatives to be pro-
duced naturally and could give rise to flavanones such as
naringenin (Figure 1). Flavones such as apigenin have low
toxicity and multiple beneficial bioactivities. Rutin possess a
double bond in ring C and further hydroxylation at the C-3
position gives rise to flavonols such as rutin and kaempferol
(Figure 1). Quercetin is a derivative of flavonols with dio-
rthohydroxyl group in the ring, while its ruinoside derivative
at the C-3 position is called rutin (Figure 1) [2].
Glycosyl flavonoids include the C-glycosides and
O-glycosides depending on the sugar attachment bound as a
C–C bond or C–O bond. Several C-glycoside flavones (e.g.,
at C-6 or C-8 position) such as rutin are more impressive in
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biological activities than O-glycosides flavone isomers [3, 4].
(e various biological activities of flavonoids include
therapeutic implications against diseases such as cancer,
depression, diabetes, dementia, lupus, autism, and heart
disease. (ey also exhibit strong antioxidative activity which
is often considered as a mechanism of action for their
healing functions in irregular biological systems such as
cancer cells. Flavonoids such as rutin are found mainly in
fruits, vegetables, grains, and many other human diets [5–7].
Several studies have shown that flavonoids as polyphenolic
compounds possess antiproliferative and cytoprotective
effects in addition to induction of apoptosis in different
cancer cell lines [8].
Some flavonoids have been shown to regulate several
signal proto-oncogene pathways. Proto-oncogenes have
been shown to encode cell surface receptors, nuclear pro-
teins, membrane proteins, growth factors, and phosphoki-
nases. C-Fos, c-Jun, and c-Myc as three important proto-
oncogenes are associated with both processes of carcino-
genesis and inflammation. In the same way, rutin induced
cytotoxicity through genotoxicity, mitochondrial apoptotic
pathway, and relatively upstream apoptotic factors, in-
cluding reduction of ROS generation and induction of
antioxidant enzyme (AOE) (Figure 2) [9, 10].
Among the nuclear proteins coded by proto-oncogenes (c-
Onc) are c-Myc, c-Fos, and c-Jun. (ese proteins have the
potential to regulate other genes directly or indirectly, thereby
influencing some gene expressions and apoptosis. (is review
aims to highlight the in vitro anticancer properties of rutin
including combination therapeutic strategies: A Novel Treat-
ment Strategy for Cancer Treatment.
1.2. Natural Occurrence and General Pharmacological Effects
of Rutin. (e metabolism, absorption, and antioxidant
activity of flavonoids significantly differ from each other
based on structural variations including the presence, na-
ture, and position of glycosylation [11]. Among the phy-
tochemicals with anticancer effects, rutin (3,3′,4′,5,7-
pentahydroxyflavone-3-rhamnoglucoside: Figure 3) is one
of the highly potent antioxidant agents, with some other
biochemical activities in cancer prevention and treatment.
Due to these biological effects, rutin is also known as vitamin
P [5, 12]. More than 130 therapeutic drugs that have been
existed are containing rutin in their structure. It is found in
plants such as buckwheat, green tea, and apples and is widely
used as medicine in China. Buckwheat is one of the major
sources of rutin [13, 14]. (e origin of rutin from the
buckwheat plant can go back to the 1940s when buckwheat
was used for medicinal purposes in the United States.
Notably, the leaves and flowers of the plant were found to
be in the highest concentration, nearly 2–10% of plant
weight. (e content of rutin at various parts of the plant
considerably depends on its geographical source and ge-
netic type [15, 16]. Moreover, it is demonstrated that more
than 70 plant species are good sources of rutin and these
include Ruta graveolens L. (Rutaceae) and Sophora japonica
L. (Fabaceae), Strelitzia reginae Banks ex Aiton (Stre-
litziaceae), Maranta leuconeura (Marantaceae), Orchid-
antha maxillarioides (Lowiaceae), Eucalyptus spp.
(Myrtaceae), Canna indica L. (Cannaceae), and Canna
edulis Ker Gawl. (Cannaceae) [15, 17]. Up to 1.5% of rutin
could also be extracted from tobacco leaves [18]. (e
biosynthesis of rutin is regulated by ultraviolet light and its
accumulation serves as a protection. In this connection,
when dill cell cultures were subjected to sunlight, the
prominent flavonoid synthesized was shown to be quer-
cetin-3-O-β-glucuronide. Both rutin and quercetin are











































Figure 1: (e structure of rutin and related flavonoids.
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Many studies revealed rutin possesses anti-inflam-
matory, anticarcinogenic, neuroprotection, anti-
proliferative, antimetastatic, and antioxidative stress
effects via inhibiting lipid peroxidation and amelioration
of oxidative stress [21, 22]. Reactive oxygen species (ROS)
can damage DNA, chromosomal mutations, unregulated
gene expressions, cell division, and cell growth. Also, they
could reduce the activities of some proteins involved in the
antioxidant systems [23, 24]. Several studies have reported
that ROS are associated with some tumors such as colon
cancer, hepatocellular carcinoma, leukaemia, neuroblas-
toma, lung cancer, and breast cancer [12, 25–27]. Lipid
peroxidation is the process by which oxygen combines
with lipids to produce lipid hydroperoxides through the
intermediate formation of peroxyl radicals and the
cleavage of hydrogen. Unless checked by antioxidants such
as rutin, lipid peroxidation can play a significant patho-
logical role. Previous studies have shown that modified
lipid composition could lead to cell apoptosis and other
effects that could be targeted by rutin. Furthermore, rutin
eliminating edema and reduction in sensitivity reduced
ischemia-reperfusion damage. Rutin provides pharmaco-
logical information via platelet aggregation and cyclo-
oxygenase-1 inhibition and its downstream pathway
(Figure 4) [28, 29].
(erefore, rutin is considered a promising natural
product in cancer prevention not only for its known efficacy
but also accessibility and limited side effects.
2. Anticancer Properties of Rutin through
Modulation of Signalling Pathways
Cancer is associated with the free radical generation and
oxidative stress, fatty acid synthase (FAS) gene expression,
and other mechanisms that lead to tumor via multiple
modifications and mutations in cell proliferation and apo-
ptosis genes controlling [1, 5]. Among the flavonoids with
anticancer effects, rutin has one of the most widespread uses
as an antioxidant and as an antitumor agent among the
flavonoids because of its abundance in the human diet such
as fruits and vegetables [30]. Here is a summary of its most
important anticancer functions.
In some types of cancer, an oncogenic change induces an
inflammatory microenvironment that promotes the devel-
opment of cancers. (e molecular pathways of this cancer-
related inflammation are now being unravelled, resulting in
the identification of new target molecules that could lead to
improved diagnosis and treatment.(ere is also evidences to
suggest that rutin exerts anti-inflammatory effects by































Figure 2: Regulation of activation of c-Fos and c-Jun proto-oncogenes on cancer cells.
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inducible nitric oxide synthase (iNOS), and suppression of
lipid peroxidation. Also, rutin suppresses proinflammatory
cytokines secretion [5, 31]. Nitric oxide is synthesized by a
family of isoenzymes in normal cells. (e high expression of
stimulation nitric oxide synthase (NOS) via myeloid-derived
suppressor cells (MDSCs) is a major signal of defence
mechanism in cancer. NOS is also expressed by cδ Tcells by
contributing to their polarization to a protumor phenotype
in cancer. Moreover, it has been indicated that rutin
modulates activators of transcription, mitogen-activated
protein kinase (MAPK), PI3K/Akt, and Wnt/β-catenin
signalling cascades and Janus kinase/signal transducers in
carcinogenic cells. (e Ras/Raf and PI3K/Akt, MAPK, and
TGF-β2/Smad2/3Akt/PTEN signalling pathways are stim-
ulated through the epidermal growth factor (EGF) signalling
pathway [14, 32, 33]. Rutin has been demonstrated to di-
rectly bind to the EGF receptor (EGFR) protein and arrest
the downstream signalling factors [5]. (ey demonstrated
that rutin reduces the expression of miR-22-5p an important
microRNA in increasing the levels of RAP1/ERK signalling
pathway-related proteins that lead to apoptosis in in vitro
and in vivo studies via Rap1a. Rap1a is one of the target
genes of miR-22-5p [14, 34]. (e present review highlights
the anticancer potentials of rutin on cancer cell lines such as
the colon, lung, breast, prostate, and HepG2 through various
known molecular mechanisms including modulation of
apoptosis genes in in vitro experimental models (Tables 1
and 2) [57].
2.1. Rutin Induces Apoptosis and Arrests the Cell Cycle in
Tumor Cells. Apoptosis is a process of eliminating damaged
cells and is executed by a family of caspases. It is regulated by
apoptotic gene expression such as p53 and Bax [58]. (e p53
gene mutation is the most common genetic irregularities
related to apoptosis in human tumors. Rutin (900 μm) was
found to downregulate the expression of mutant p53 protein
in human prostate cancer cell lines (DU-145, PC-3, and
LNCaP) [21, 59].
(e G1 and G2 phases of the cell cycle controlled by the
p53 gene are a main regulatory mechanism in cellular
proliferation [20]. Many studies demonstrated that rutin
increases glutathione S-transferase P1 (GSTP1) polymor-
phism, Cyp1A1 cytochrome P450 (CYP1A1, CYP2D6)
polymorphisms (inhibitory effect of antitumor genes), p53
(apoptosis gene expression), and Nqo-1 (antioxidant en-
zyme) leading to cell cycle arrest and consequently induction
of apoptosis [21, 46, 60]. Also, it was reported that rutin
could decrease Bcl-2 antiapoptosis gene expression and Bcl-
2/Bax ratio along with a reduction in the levels of MYCN
mRNA [61] (Figure 5). Moreover, other studies suggest that
rutin can inhibit and regulate the cell cycle in the G2 and G1
phases. It stimulates apoptosis and decreases some of the
oncogenic pathways including NF-κβ pathway and phos-
phorylation of the p38 MAP kinase [60, 62]. (erefore, these
studies brought to light the unique roles of rutin in the
prevention and treatment of cancer via the control of cellular
proliferation and apoptosis induction [9].
2.2. Anticancer Effect of Rutin: Single 9erapy on Cancer Cell
Lines. (ere are numerous in vitro studies that investigate
the effect of rutin on the proliferation of cancer cell lines,
such as the breast, colon, prostate, and lung. Rutin caused
growth inhibition in human glioblastoma cell lines through
induction of apoptosis and G2/M phase cell cycle arrest, as
well as regulation of expression of the pro- and antiapoptotic
genes (Bcl-2, Cas-3, Bax, and TP53). It also reduced mito-
chondrial membrane potential [62]. Rutin (400–700mM/
ml) has shown in vitro antiangiogenic properties on SW480
(human colon adenocarcinoma cell line) through cell cycle
arrest at G1 phase and regulation of microRNAs (miRNAs),
long noncoding RNAs (lncRNAs), messenger RNAs































Figure 4: Rutin can reduce the expression of proinflammatory cytokines (TNF-α, IL-6, IL-1β, and COX-2) and downregulate inflammatory
markers and antiproliferative impact.(is anti-inflammatory activity is primarily related to the regulation onMAPKs and NF-κB signalling
pathways by in vivo and in vitro data (66).
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well as other antioxidants such as gallic acid, chlorogenic
acid, coumaric acid, quercetin, and ferulic acid also induced
cell apoptosis via a caspase-independent pathway [63]. In
another cancer, osteosarcoma, it was further reported that
rutin can stimulate osteoblast in human MG-63 cells
[31, 64]. Other studies demonstrate that rutin exerts a
Table 1: (e anticancer activities of rutin combination with other antioxidants or herbal ingredients.
Compound (rutin with
other agents) Mechanism Cancer cell line Reference
Quercetin, myricetin Protection of cancer cells against hydrogenperoxide Caco-2 and HepG2 [35, 36]
Quercetin Decrease the activity of oxygen radical Human hepatocellular carcinoma (HepG2) [37–39]
AgNPs and natural bioactive
compounds
Represent novel therapeutics fighting and
synergistic, antimicrobial effects
Epithelioma papulosum cyprini (EPC) cell
lines [40]
Dietary polyphenols Inducing cell cycle arrest or apoptosis,metastasis, and angiogenesis Colorectal cancer cell lines [41]
Fucoidan Nuclear fragmentation, and mitochondrialpotential loss, ROS generation
HaCaT (immortal noncancerous
keratinocyte), HeLa (epithelial




Inhibited the genes, namely, Nox2B and Nox4,
which caused oxidative stress, upregulation in
the expression of the antioxidant genes Gclc and
Nqo-1
Human bronchial epithelial cells (BEAS-2B) [36, 42]
Quercetin Reduce the enzymes precarcinogeniccompounds such as CYP1A Intestinal HCT-8 Cells [38, 42]
Diosmin and Tangeretin Antimetastatic effects Melanoma B16F10 cancer cells [43]
Zinc(II) flavonoid-metal
complex
Modulated expression of genes related to
angiogenesis, cell cycle progression
Leukaemia (KG1, K562, and Jurkat),
melanoma (B16F10 and SK-Mel-28), and
multiple myeloma (RPMI8226) cell lines
[44]
Ionic liquids nanoparticles Caused a significant increase in the sub-G1population, a significant decrease in cell viability Human renal cancer cell line (786-O) [45]
Silibinin
Anticancer, apoptosis effects regulating the
expressions of genes apoptosis, inflammation,
and MAPK pathway proteins




Cell cycle disruption and apoptotic induction MDA-MB-231 [47]
Table 2: (e anticancer activities of rutin combination with other therapeutically drugs as revealed by recent studies in vitro.
Compound (rutin with other
therapeutically drugs) Mechanism Cancer cell line Reference
Apigenin, tamoxifen Induce apoptosis through a p53-dependent pathway Breast cancer cell line (MCF-7) [48]
Cisplatin, isoquercetin
Inducing toxicity, could decrees cell count percentage in
G0/G1, S, and G2/M phases in addition to increase it in
sub G0 phase in comparison with the single doses
Gastric cancer [49]
Hyperoside Increase the expression of regulator positive apoptosissuch as Bax, Caspase 3, 8, 9 Colon cancer cells (HT-29) [50]
5-FU Increase of p53 gene expression and decreases Bcl-2protein expression Prostate cancer cell (PC3) [21]
Oxaliplatin Induced apoptosis may be associated with the activationof the p38/caspase signal pathway SGC-7901 gastric cancer cell line [51]
Orlistat Cytotoxic effects and promoting apoptosis
Breast cancer (MCF-7) and
pancreatic cancer cell line
(PANC-1)
[5]
Oxidovanadium(IV) Inhibit superoxide, hydroxyl radicals and improved theantioxidant activity Lung cancer A549 cell line [52]
5-FU and oxaliplatin Antiproliferative effect and reduce possible adverseeffects of these drugs Caco-2 cancer cell line [53]
Zein-co-acrylic acid hybrid
hydrogels loaded 5-fluorouracil Enhanced anticancer efficacy
MDA-MB-231 and MCF-7
breast cancer cell lines [54, 55]
Doxorubicin (DOX) Anticancer, protective effects Human neuroblastoma cell line(IMR32) [56]
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notable reduction in tumor extent on human leukaemia
(HL-60) and hepatic cells [65–67]. Also, rutin significantly
inhibited the growth of LAN-5 and neuroblastoma cells
through induction of apoptosis and cycle arrest at the G2/M
phase [61]. Some studies indicated that rutin (810 μm) can
cause a decrease in viability and consequently induce ap-
optosis in human liver cells [66, 68]. In breast cancer MDA-
MB-231 cells, MCF-7 cell line, and HTC hepatic cells, rutin
has been shown to modulate the Wnt, JAK-STAT, EGF
signalling, AP-1, NF-κB, and Akt [69, 70]. (erapeutically
controlling cell signalling using different antioxidants has
been demonstrated to have promise in cancer though it still
needs more research [69]. In studies conducted by Karakurt
on human hepatocytes (HepG2), rutin showed a regulatory
role in the expression of cytochrome P450 and antioxidant
enzymes [60]. Another study indicated a defensive effect of
rutin on LLC-PK1 cells (a porcine renal tubular epithelial
cell line) that caused cell death and production of intra-
cellular ROS [5, 71]. It also exerts in vitro cytotoxic effects on
prostate cancer cells via increased caspase activity and ap-
optosis [72]. Moreover, rutin could be a candidate thera-
peutic agent for the treatment of human lung (A549) and
colon (HT-29 and Caco-2) cancer cell lines by decreasing cell
viability [53, 73]. Rutin treatment could significantly inhibit
endothelial cell proliferation in vitro with the implication of
angiogenesis inhibition [56]. So, rutin seems to be useful as
an adjuvant in cancer therapy and the evidence shows that it
alone has some anticancer potentials.
2.3. Rutin as a Combination 9erapy with Antioxidants or
Herbal Ingredients in Cancer Cells In Vitro. Combination
therapy, the main treatment strategy that combines two or
more therapeutic agents, is recently used by many investi-
gators for cancer therapy. It has been shown that the mixture
of antioxidants can promote antiproliferative, anticarcino-
genic effects when compared to the monotherapy approach
in cancer [48, 74, 75] (Table 1). (e results have shown that
rutin prenanoemulsion could inhibit cancer cells such as
lung cancer cell line (A549) and colon cancer cell line. Also,
the effects of rutin with antioxidants prevented protein
modifications by lipid peroxidation products. Further, it
induced rutin-protein adduct formation, which supports
intra/extracellular signalling and the Nrf2/ARE antioxidant
pathway, contributing to the protective effects against UV-
induced oxidative stress [76].
Regulation of cellular signalling pathways such as Wnt/
β-catenin, p53-independent pathway, apoptosis, JAK/STAT,
PI3K/Akt, and MAPK as well as NF-κB signalling pathways
helps to mediate the anticancer effects of rutin. Exploration
of these antitumor mechanisms can facilitate the develop-
ment of this beneficial compound for its application in the
treatment of cancers [77–79].
2.4. Rutin inCombinationwithChemotherapyDrugs: InVitro
Studies. Randomized clinical trials have shown that the
administration of antioxidants with chemotherapeutic drugs
offers the possibility of better tumor protection and survival
[74, 80]. Also, previous studies have demonstrated that rutin
in combination with drugs can reduce the proliferation of
many cancer cells through activation of apoptosis and arrest
the cell cycle and many other mechanisms (Table 2).
(erefore, the present review aimed to show the synergistic
effects of rutin with anticancer drugs in cancer cell lines
(Table 2). Rutin was demonstrated to target various in-
flammatory, apoptotic, autophagic, and angiogenic signal-
ling mediators, including nuclear factor-κB, tumor necrosis
factor-α, interleukins, light chain 3/Beclin, B cell lymphoma
2 (Bcl-2), Bcl-2 associated X protein, caspases, and vascular
endothelial growth factor [40, 81]. A critical analysis of the
anticancer potential of rutin and associated molecular tar-
gets among various cancer types has not been performed
previously. Moreover, combination therapy can lead to a

















Figure 5: In a pathway independent of transcription, themitochondrial p53 is bonded to Bcl-2 oncoprotein and Bcl-x proteins which reduce
their inhibitory effect on the Bak and Bax apoptotic proteins. Bcl-2 promoted cell survival by blocking chemotherapy-induced apoptosis.
(erefore, p53 leads to mitochondrial permeability and cytochrome C release consequently and activation apoptosis (21).
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3. Applications of Novel Drugs and Limitations
Associated with the Use of Some Flavonoids
Such as Rutin
Great advances have beenmade on the development of novel
drug combination systems for plant actives. (e variety of
novel herbal formulations like Rutin as a promising can-
didate in combination with other antitumor drugs or alone
has been reported for cancer treatment by decreasing the
exposure in normal tissues exploiting enhanced permeability
and retention effect phenomenon by utilizing targeting
strategies. Also, improve the efficacy of herbal cosmetic
formulations on the human body. (e mentioned formu-
lations demonstrated that they have remarkable advantages
of rutin which include enhancement of solubility, protection
from toxicity, bioavailability enhancement of pharmaco-
logical activity, and stability. (ese criteria have improved
tissue macrophages distribution and protection from
physical and chemical degradation. Also, reduce medicinal
doses and improve the absorbency of herbal medicines
compared with single therapy [83–86].
Clinical studies have supported effects as a car-
dioprotective and neuroprotective agent. (e combination
of polyphenols with existing drugs also shows promising
results and significantly reduces their toxicity. (e major
limitation to the use of these plants is the side effects as-
sociated with their use in high doses due to their neurotoxic
side effect and cardiac function, apoptosis, and necroptosis.
During the clinical study, we reported a mixture of rutin,
diosmin, troxerutin, hesperidin, and quercetin in the
treatment of I–III degree hemorrhoidal disease in different
time can effectively mean managing bleeding from hem-
orrhoidal disease and minimal adverse events [84, 87, 88].
4. Conclusion
(is review summarizes that rutin can be a promising
candidate in combination with drugs for cancer treatment in
vitro. It has been shown that the antitumor effect of rutin is
related to interactions with signalling processes such as
mixed-lineage protein kinase 3, Wnt, and mitogen-activated
protein kinase. Furthermore, it demonstrated that it inhibits
cell proliferation and regulates apoptosis and cell cycle in
cancer cell lines and helps to design the best therapeutic
strategies. However, more future studies are needed to
understand the proper mechanism of action of rutin on
cancer cell lines. Also, further investigations are needed to
assess rutin in combination or alone on the expression of
anti- or proapoptotic pathways and genes and other
ingredients.
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K. Elżbieta, “Rutin and ascorbic acid cooperation in anti-
oxidant and antiapoptotic effect on human skin keratinocytes
and fibroblasts exposed to UVA and UVB radiation,”Archives
of Dermatological Research, vol. 311, no. 3, pp. 203–219, 2019.
[9] G. Chen, 9e Molecular Basis for Tumor Growth Suppression
by tRNA Methyltransferase 9-Like (TRM9L), MIT Libraries,
Cambridge, MA, USA, 2017.
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